TRACON Pharmaceuticals In...
(TCON)
undefined
undefined%
At close: undefined
1.08
3254.04%
After-hours Jun 27, 2024, 07:53 PM EDT
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
Revenue | 12.04M | - | 346.00K | - | - | 3.00M | 8.76M | 3.45M | 7.90M | 3.60M | - | - |
Cost of Revenue | 14.00K | 16.00K | 14.00K | 12.00K | 22.00K | 30.46M | 19.36M | 15.24M | 20.43M | 4.85M | 3.98M | 2.09M |
Gross Profit | 12.03M | -16.00K | 332.00K | -12.00K | -22.00K | -27.46M | -10.60M | -11.79M | -12.53M | -1.25M | -3.98M | -2.09M |
Operating Income | -6.90M | -27.89M | -28.35M | -16.22M | -22.30M | -34.74M | -18.21M | -25.98M | -23.47M | -6.18M | -7.56M | -5.23M |
Interest Income | - | 994.00K | 318.00K | 545.00K | 386.00K | - | - | - | - | - | - | - |
Pretax Income | -3.59M | -29.14M | -28.67M | -16.77M | -22.67M | -34.96M | -19.10M | -27.01M | -24.41M | -6.81M | -7.71M | -4.93M |
Net Income | -3.59M | -29.31M | -28.73M | -17.33M | -22.66M | -34.96M | -19.10M | -27.01M | -24.41M | -6.81M | -7.71M | -4.93M |
Selling & General & Admin | 6.67M | 14.01M | 17.55M | 8.03M | 7.77M | 7.28M | 7.61M | 7.86M | 5.69M | 2.13M | 1.48M | 1.45M |
Research & Development | 12.28M | 13.89M | 11.15M | 8.20M | 14.53M | 30.46M | 19.36M | 21.57M | 25.68M | 7.65M | 6.08M | 3.78M |
Other Expenses | - | -1.24M | -320.00K | -7.00K | -378.00K | 12.00K | - | - | - | - | - | - |
Operating Expenses | 18.93M | 27.89M | 28.69M | 16.22M | 22.30M | 37.74M | 26.96M | 29.43M | 31.37M | 9.78M | 7.56M | 5.23M |
Interest Expense | 7.30M | 994.00K | 318.00K | 545.00K | 386.00K | 231.00K | 886.00K | 1.12M | 923.00K | 667.00K | 30.00K | - |
Selling & Marketing Expenses | - | - | - | - | - | - | - | - | - | - | - | - |
Cost & Expenses | 18.94M | 27.89M | 28.69M | 16.22M | 22.30M | 37.74M | 26.96M | 29.43M | 31.37M | 9.78M | 7.56M | 5.23M |
Income Tax | - | 177.00K | 59.00K | 551.00K | -16.00K | 12.00K | 845.00K | 938.00K | 892.00K | 615.00K | 30.00K | - |
Shares Outstanding (Basic) | 1.63M | 1.05M | 862.63K | 448.53K | 151.72K | 134.73K | 84.03K | 63.39K | 55.58K | 59.89K | 2.45K | 161.49K |
Shares Outstanding (Diluted) | 1.64M | 1.05M | 862.63K | 449.21K | 151.72K | 134.73K | 84.03K | 63.39K | 55.58K | 59.89K | 2.45K | 161.49K |
EPS (Basic) | -2.2 | -28.02 | -33.3 | -38.63 | -149.35 | -259.47 | -227.33 | -426.06 | -439.2 | -113.7 | -3.14K | -30.52 |
EPS (Diluted) | -2.19 | -28.02 | -33.3 | -38.57 | -149.35 | -259.47 | -227.33 | -426.06 | -439.2 | -113.7 | -3.14K | -30.52 |
EBITDA | -6.88M | -27.89M | -28.33M | -16.22M | -22.27M | -34.71M | -18.17M | -25.80M | -23.42M | -6.16M | -7.55M | -5.22M |
Depreciation & Amortization | 14.00K | 16.00K | 14.00K | 12.00K | 22.00K | 28.00K | 48.00K | 94.00K | 51.00K | 15.00K | 7.00K | 6.00K |